ADVFN - ニュース

US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/07/31	05 : 02	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:VXX	iPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/07/31	05 : 02	Business Wire	PepGen Announces Positive Data from Low-Dose Cohort of PGN-EDO51 in Ongoing CONNECT1-EDO51 Phase 2 Clinical Trial for Treatment of Duchenne Muscular Dystrophy	NASDAQ:PEPG	PepGen Inc
2024/07/31	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PSIX	Power Solutions Intl Inc (PK)
2024/07/31	05 : 01	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NYSE:NUVB	Panacea Acquisition Corp
2024/07/31	05 : 01	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:JPM-M	JP Morgan Chase and Co
2024/07/31	05 : 01	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:GS-J	Goldman Sachs Group Inc
2024/07/31	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SWTX	SpringWorks Therapeutics Inc
2024/07/31	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AVTX	Avalo Therapeutics Inc
2024/07/31	05 : 01	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NYSE:VSTO	Vista Outdoor Inc
2024/07/31	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NRDS	NerdWallet Inc
2024/07/31	05 : 01	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:VXX	iPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/07/31	05 : 01	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	USOTC:EFTR	eFFECTOR Therapeutics Inc (PK)
2024/07/31	05 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HEES	H and E Equipment Services Inc
2024/07/31	05 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:PLOW	Douglas Dynamics Inc
2024/07/31	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PCRX	Pacira BioSciences Inc
2024/07/31	05 : 01	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:BML-L	Bank of America Corporation
2024/07/31	05 : 01	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:GS-J	Goldman Sachs Group Inc
2024/07/31	05 : 01	PR Newswire (US)	Hawaiian Holdings Reports 2024 Second Quarter Financial Results	NASDAQ:HA	Hawaiian Holdings Inc
2024/07/31	05 : 01	Business Wire	Advanced Energy Reports Second Quarter 2024 Results	NASDAQ:AEIS	Advanced Energy Industries Inc
2024/07/31	05 : 01	Business Wire	AtriCure Reports Second Quarter 2024 Financial Results	NASDAQ:ATRC	AtriCure Inc
2024/07/31	05 : 01	Business Wire	Delcath Systems to Participate in Upcoming Investor Conferences	NASDAQ:DCTH	Delcath Systems Inc
2024/07/31	05 : 01	PR Newswire (US)	CarParts.com Reports Second Quarter 2024 Results	NASDAQ:PRTS	CarParts com Inc
2024/07/31	05 : 01	Business Wire	First Keystone Announces Second Quarter 2024 Earnings (Unaudited)
2024/07/31	05 : 01	Business Wire	Skyworks Reports Q3 FY24 Results	NASDAQ:SWKS	Skyworks Solutions Inc
2024/07/31	05 : 01	Business Wire	Caesars Entertainment, Inc. Reports Second Quarter 2024 Results	NASDAQ:CZR	Caesars Entertainment Inc
2024/07/31	05 : 00	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:JPM-M	JP Morgan Chase and Co
2024/07/31	05 : 00	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:WAFU	Wah Fu Education Group Ltd
2024/07/31	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATRC	AtriCure Inc
2024/07/31	05 : 00	Edgar (US Regulatory)	Form DEF 14C - Other definitive information statements	USOTC:CRCW	Crypto Company (PK)
2024/07/31	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HSPOU	Horizon Space Acquisition I Corporation

1 2 3 4 5 6 7 8 9 10 次へ >>

Health Care Select Sector

Financial Select Sector

US Dollar vs Euro

Gold vs US Dollar

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約